ArticleMethods in enzymology2025
Unmasking a hidden code during transcription: A practical strategy to reveal Thr4 phosphorylation in RNA polymerase II.
Article in Methods in enzymology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
RNA Polymerase II (Pol II) is core to cell survival as the responsible enzyme for transcription of mRNA as well as various non-coding RNA species. The post-translational modification (PTM) of the C-terminal domain (CTD) of its largest subunit RPB1, principally through phosphorylation, enables docking of relevant proteins to govern the transcription cycle and RNA processing. The detection of phosphorylated Thr4 of the CTD heptad motif is exacerbated by epitope masking due to phosphorylations on nearby residues, thereby decreasing antibody recognition of the target epitope. Here, we introduced ChIP-phos-seq, wherein we conducted chromatin immunoprecipitation with phosphatase treatment followed by sequencing. This method addressed the overlooked phosphorylated Thr4 by removing masking phosphomarks with the targeted, specific phosphatase, Ssu72. In order to perform ChIP-phos-seq, Ssu72 was purified and characterized for specificity and activity through mass spectrometry and kinetics assays. The phosphatase treatment was optimized and used as a tool to target the masked phosphorylated Thr4 epitopes recognized in an antibody pulldown. Sequencing the DNA bound to Pol II then allows the CTD Thr4 phosphorylation to be profiled and analyzed for its presence on different gene types, lengths, and ontologies. With a clearer view of phosphorylated Thr4, a better understanding of how Thr4 phosphorylation contributes to transcription regulation and transcript processing is achievable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.